Hyperhidrosis Treatment


The COVID-19 epidemic is a historic public health concern that has had a substantial influence on the global market for hyperhidrosis treatment. At the moment, countries throughout the world are struggling to obtain some medications because to shutdown limitations and the advent of new COVID-19 variations. According to a January 2021 published study titled “Paroxysmal hypothermia and hyperhidrosis with aggravation following COVID-19 infection,” hypothermia alternated with fever for four days during the acute phase of…